British Journal of Anaesthesia, Vol 84, Issue 3 378-393, Copyright © 2000 by Oxford University Press
JE Arrowsmith, HP Grocott, JG Reves and MF Newman
The neurological complications of cardiac surgery are associated with
significantly increased mortality, morbidity and resource utilization. The
use of new surgical techniques, introduction of wider indications for
surgery and increased public expectation has led to an increase in the
average age of cardiac surgical patients and an increased incidence of
repeat procedures. With these changes has come an increased risk of
neurological complications. The likelihood of perioperative stroke varies
between 1% and 5% in most published series and is dependent on a multitude
of risk factors. Of these, patient age, aortic atheroma, symptomatic
cerebrovascular disease, diabetes mellitus and the type of surgery appear
to be most important. Cognitive deterioration after cardiac surgery is far
more common, affecting as many as 80% of patients a few days after surgery
and persisting in one-third. Despite an increase in the age of the cardiac
surgical population, the reported incidence of cognitive dysfunction after
cardiac surgery seems to have fallen in recent years. Whether this is a
real phenomenon or the result of changes in the use of psychometric testing
and the definition of cognitive decline remains unclear. Recognition that
certain equipment, surgical practices and patient factors contribute to
neurological morbidity has prompted 'neuroprotective' interventions. Some
of these (e.g. arterial line filtration and alpha-stat management) have
been shown to improve outcome. Despite these measures, a small number of
patients will inevitably sustain cerebral injury during otherwise
successful cardiac surgery. Although pharmacological neuroprotection may,
in the future, offer some of these patients an improved outcome, it is
unlikely that any single agent will prevent neurological injury. In the
meantime, the CNS complications of cardiac surgery remain a fertile area of
research.
ARTICLES
Central nervous system complications of cardiac surgery
Department of Anaesthesia, Papworth Hospital, Papworth Everard, Cambridge, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. P. Grocott PRO: Temperature Regimens and Neuroprotection During Cardiopulmonary Bypass: Does Rewarming Rate Matter? Anesth. Analg., December 1, 2009; 109(6): 1738 - 1740. [Full Text] [PDF] |
||||
![]() |
L. A. Evered, B. S. Silbert, D. A. Scott, P. Maruff, K. M. Laughton, I. Volitakis, T. Cowie, R. A. Cherny, C. L. Masters, and Q.-X. Li Plasma Amyloid beta(42) and Amyloid beta(40) Levels Are Associated With Early Cognitive Dysfunction After Cardiac Surgery. Ann. Thorac. Surg., November 1, 2009; 88(5): 1426 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sahu, S. Chauhan, U. Kiran, A. Bisoi, L. Ramakrishnan, and A. Nehra Neuropsychological function in children with cyanotic heart disease undergoing corrective cardiac surgery: effect of two different rewarming strategies Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 505 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Jensen, L. S. Rasmussen, and D. A. Steinbruchel Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1016 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Silbert, L. A. Evered, D. A. Scott, and T. F. Cowie The Apolipoprotein E {epsilon}4 Allele is not Associated With Cognitive Dysfunction in Cardiac Surgery Ann. Thorac. Surg., September 1, 2008; 86(3): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dingley and R. S. Mason A Cryogenic Machine for Selective Recovery of Xenon from Breathing System Waste Gases Anesth. Analg., November 1, 2007; 105(5): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ramlawi, H. Otu, J. L. Rudolph, S. Mieno, I. S. Kohane, H. Can, T. A. Libermann, E. R. Marcantonio, C. Bianchi, and F. W. Sellke Genomic expression pathways associated with brain injury after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 996 - 1005.e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zervakis, P. Angelidakis, P. Dedeilias, and A. Koutsoukou Cerebral vein thrombosis after coronary artery bypass surgery Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 514 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Silbert, D. A. Scott, L. A. Evered, M. S. Lewis, and P. T. Maruff Preexisting Cognitive Impairment in Patients Scheduled for Elective Coronary Artery Bypass Graft Surgery Anesth. Analg., May 1, 2007; 104(5): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kadoi Pharmacological Neuroprotection During Cardiac Surgery Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 167 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kumar, C. Cann, J. E. Hall, P. S. Sudheer, and A. R. Wilkes Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass Br. J. Anaesth., March 1, 2007; 98(3): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Keith, D. J. Cohen, and L. B. Lecci Why Serial Assessments of Cardiac Surgery Patients' Neurobehavioral Performances are Misleading Ann. Thorac. Surg., February 1, 2007; 83(2): 370 - 373. [Full Text] [PDF] |
||||
![]() |
I. Szalma, A. Kiss, L. Kardos, G. Horvath, E. Nyitrai, Z. Tordai, and L. Csiba Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo. Ann. Thorac. Surg., October 1, 2006; 82(4): 1430 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carrier, A. Denault, J. Lavoie, and L. P. Perrault Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Ann. Thorac. Surg., July 1, 2006; 82(1): 51 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hogue Jr, C. A. Palin, and J. E. Arrowsmith Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth. Analg., July 1, 2006; 103(1): 21 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, R. Taha, D. Gauvin, L. B. Othmen, Y. Wang, and G. Blaise Postoperative Cognitive Dysfunction After Cardiac Surgery Chest, November 1, 2005; 128(5): 3664 - 3670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Svenmarker, K G Engstrom, T Karlsson, E Jansson, R Lindholm, and T Aberg Influence of pericardial suction blood retransfusion on memory function and release of protein S100B Perfusion, December 1, 2004; 19(6): 337 - 343. [Abstract] [PDF] |
||||
![]() |
M. F. Newman, J. A. Blumenthal, and D. B. Mark Fixing the Heart: Must the Brain Pay the Price? Circulation, November 30, 2004; 110(22): 3402 - 3403. [Full Text] [PDF] |
||||
![]() |
B. S. Silbert, P. Maruff, L. A. Evered, D. A. Scott, M. Kalpokas, K. J. Martin, M. S. Lewis, and P. S. Myles Detection of cognitive decline after coronary surgery: a comparison of computerized and conventional tests Br. J. Anaesth., June 1, 2004; 92(6): 814 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nagels, R. Demeyere, J. Van Hemelrijck, E. Vandenbussche, K. Gijbels, and E. Vandermeersch Evaluation of the Neuroprotective Effects of S(+)-Ketamine During Open-Heart Surgery Anesth. Analg., June 1, 2004; 98(6): 1595 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B Scott, E. Farmer, A. Smiton, C. Tovey, M. Clarke, and K. Carpenter Methodology of neuropsychological research in multicentre randomized clinical trials: a model derived from The International Subarachnoid Aneurysm Trial Clinical Trials, February 1, 2004; 1(1): 31 - 39. [Abstract] [PDF] |
||||
![]() |
B. Reinsfelt, A. Westerlind, E. Houltz, S. Ederberg, M. Elam, and S.-E. Ricksten The Effects of Isoflurane-Induced Electroencephalographic Burst Suppression on Cerebral Blood Flow Velocity and Cerebral Oxygen Extraction During Cardiopulmonary Bypass Anesth. Analg., November 1, 2003; 97(5): 1246 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V Kalpokas, I. K Nixon, R. Kluger, D. S Beilby, and B. S Silbert Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial Perfusion, September 1, 2003; 18(5): 291 - 294. [Abstract] [PDF] |
||||
![]() |
E. Ahlgren, A. Lundqvist, A. Nordlund, C. Aren, and H. Rutberg Neurocognitive impairment and driving performance after coronary artery bypass surgery Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vaage and R. Anderson Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100{beta} J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S31 - 33. [Full Text] [PDF] |
||||
![]() |
J. Vaage and R. Anderson Biochemical markers of neurologic injury in cardiac surgery: The rise and fall of S100{beta} J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 853 - 855. [Full Text] [PDF] |
||||
![]() |
H. J. Nathan, G. A. Wells, J. L. Munson, and D. Wozny Neuroprotective Effect of Mild Hypothermia in Patients Undergoing Coronary Artery Surgery With Cardiopulmonary Bypass: A Randomized Trial Circulation, September 18, 2001; 104 (2009): I-85 - I-91. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Millar, A. J. Asbury, and G. D. Murray Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery Br. J. Anaesth., January 1, 2001; 86(1): 63 - 67. [Abstract] [Full Text] [PDF] |
||||










